Experimental study reveals that TDP-43 mutations impair autophagic flux via RILP downregulation in motor neurons, indicating a targetable mechanism in amyotrophic lateral sclerosis.
TDP-43 has many functions, including the regulation of autophagy and stress granule dynamics, and mutations in TDP-43 are causative of amyotrophic lateral sclerosis (ALS). Among these, the G376D mutation is associated with TDP-43 cytoplasmic mislocalization and mitochondrial and lysosomal dysfunctions. We discovered that upon TDP-43 silencing, the abundance of RILP, a RAB7A effector, decreases. Similarly, expression of the ALS-causative G376D mutant protein reduces RILP intracellular levels, compromising the autophagic flux. RILP overexpression restores the autophagic flux and reduces stress granule marker levels, demonstrating that RILP can overcome TDP-43 malfunctioning. Mechanistically, we show that TDP-43 controls RILP expression mainly at a translational level. L-leucine restored RILP levels in TDP-43-depleted and TDP-43 G376D -expressing cells, whereas inhibition of mTOR signaling or protein synthesis abolished this effect. Polysome profiling further demonstrated that TDP-43 depletion reduces the association of RILP mRNA with heavy polysomes, supporting impaired translational efficiency. RILP downregulation and defective autophagic flux were confirmed in iPSC-derived TDP-43 G376D motor neurons, where RILP overexpression improved autophagy and cell viability. In addition, TDP-43 co-immunoprecipitates with both RILP and RAB7A, although only RILP interacts directly with TDP-43. The interaction occurs between the RILP C-terminus and amino acids 320–346 of TDP-43. Interestingly, the TDP-43 mutant displays a stronger interaction with RILP, and its expression reduces RILP-RAB7A interaction, suggesting that pathogenic TDP-43 perturbs the functional coupling between them. These data identify RILP as a new TDP-43 interactor and reveal that disruption of the TDP-43/RILP/RAB7A axis, induced by TDP-43 G376D , contributes to defective autophagy that characterizes ALS and possibly other neurodegenerative disorders.
No takes yet. Share an insight, caveat, or question.
Romanò et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: